Autopsy report · NCT00959738

Diverting Loop Ileostomy: With or Without Rod

“Difference found in interim analysis, not ethical to continue”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year after it had already started.
• Ran for about 6 years 3 months before it stopped.
• 121 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Insel Gruppe AG, University Hospital Bern

Sponsor type

University, hospital or other

Conditions

Ileostomy; Rectal Neoplasms

Interventions

Diverting loop ileostomy with rod; diverting loop ileostomy without rod

Participants

121

Sites

1

Countries

Switzerland

Trials that died the same way

• Moxonidine in Patients Undergoing Vascular Surgery
  “Study was stopped after pre-definied interim analysis because of no effects” (71% match in meaning)
• ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients
  “Lack of effect in interim analysis” (70% match in meaning)
• Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer
  “Interim analysis determined the study did not meet criteria to proceed” (69% match in meaning)
• Conversational Hypnosis in Women Undergoing Imaging for Breast Cancer
  “Results not achievable after interim analysis conclusions and recruting difficulty” (69% match in meaning)
• Adherence to Antidepressant Treatment in Subjects With Depression
  “The study was terminated early based on the planned interim analysis that did not meet criteria for continuation.” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.